Term | Code | Class | Title |
---|---|---|---|
2023 S1 | MMPH6139 | 1C | Techniques and Applications of Molecular Pathology |
2023 S2 | PATH6204 | 2A | Haematological cytology and ancillary techniques in cytopathology |
2023 S1 | PATH6207 | 1A | Techniques and applications of molecular pathology |
2023 S1 | MMPH6139 | 1A | Techniques and Applications of Molecular Pathology |
2023 S2 | MMDP7003 | 2A | Fundamentals of Genetic Testing for Hereditary Disorders |
2023 S1 | MMDP7002 | 1A | Clinical Applications of Molecular Testing |
2023 S2 | BCHM3606 | FA | Pathology |
2023 S2 | BBMS3004 | 2A | Molecular Diagnostics Laboratory |
2023 S2 | BBMS3003 | 2A | Mechanisms and Pathology of Diseases |
2023 S1 | PATH6600 | 1A | Fundamentals of Common Human Diseases |
2023 S1 | BCHM3606 | FA | Pathology |
2022 S2 | BCHM3606 | FA | Pathology |
2022 S1 | BCHM3606 | FA | Pathology |
2022 S1 | MMPH6139 | 1C | Techniques and Applications of Molecular Pathology |
2022 S1 | MMPH6139 | 1A | Techniques and Applications of Molecular Pathology |
2022 S2 | BBMS3004 | 2A | Molecular Diagnostics Laboratory |
2022 S2 | BBMS3003 | 2A | Mechanisms and Pathology of Diseases |
2022 S1 | PATH6600 | 1A | Fundamentals of Common Human Diseases |
2022 S1 | PATH6207 | 1A | Techniques and applications of molecular pathology |
2021 S2 | BCHM3606 | FA | Pathology |
2021 S1 | MMPH6139 | 1C | Techniques and Applications of Molecular Pathology |
2021 S2 | PATH6204 | 2A | Haematological cytology and ancillary techniques in cytopathology |
2021 S2 | PATH6005 | 2A | Essential Anatomical Pathology for Clinicians |
2021 S2 | BBMS3004 | 2A | Molecular Diagnostics Laboratory |
2021 S2 | BBMS3003 | 2A | Mechanisms and Pathology of Diseases |
2021 S1 | PATH6600 | 1A | Fundamentals of Common Human Diseases |
2021 S1 | PATH6207 | 1A | Techniques and applications of molecular pathology |
2021 S1 | MMPH6139 | 1A | Techniques and Applications of Molecular Pathology |
2020 S2 | BCHM3606 | FA | Pathology |
2020 S1 | BCHM3606 | FA | Pathology |
2020 S1 | MMPH6139 | 1A | Techniques and Applications of Molecular Pathology |
2020 S1 | MMPH6139 | 1C | Techniques and Applications of Molecular Pathology |
2020 S2 | PATH6003 | 2A | Fundamentals of Genetic Testing for Hereditary Disorders |
2020 S2 | PATH6002 | 2A | Clinical Applications of Molecular Testing |
2020 S2 | BBMS3004 | 2A | Molecular Diagnostics Laboratory |
2020 S2 | BBMS3003 | 2A | Mechanisms and Pathology of Diseases |
2020 S1 | PATH6600 | 1A | Fundamentals of Common Human Diseases |
2020 S1 | PATH6207 | 1A | Techniques and applications of molecular pathology |
2019 S2 | PATH6204 | 2A | Haematological cytology and ancillary techniques in cytopathology |
2019 S2 | PATH6005 | 2A | Essential Anatomical Pathology for Clinicians |
2019 S2 | BCHM3606 | FA | Pathology |
2019 S2 | BBMS3004 | 2A | Molecular Diagnostics Laboratory |
2019 S2 | BBMS3003 | 2A | Mechanisms and Pathology of Diseases |
2019 S1 | PATH6600 | 1A | Fundamentals of Common Human Diseases |
2019 S1 | PATH6207 | 1A | Techniques and applications of molecular pathology |
2019 S1 | MMPH6139 | 1C | Techniques and Applications of Molecular Pathology |
2019 S1 | MMPH6139 | 1A | Techniques and Applications of Molecular Pathology |
2019 S1 | BCHM3606 | FA | Pathology |
2018 S1 | BCHM3606 | FA | Pathology |
2018 S2 | BBMS3003 | 2A | Mechanisms and Pathology of Diseases |
2018 S2 | PATH6003 | 2A | Fundamentals of Genetic Testing for Hereditary Disorders |
2018 S1 | MMPH6139 | 1A | Techniques and Applications of Molecular Pathology |
2018 S1 | PATH6207 | 1A | Techniques and applications of molecular pathology |
2018 S1 | PATH6600 | 1A | Fundamentals of Common Human Diseases |
2018 S2 | BBMS3004 | 2A | Molecular Diagnostics Laboratory |
2018 S2 | BCHM3606 | FA | Pathology |
2018 S2 | PATH6002 | 2A | Clinical Applications of Molecular Testing |
2018 S1 | MMPH6139 | 1C | Techniques and Applications of Molecular Pathology |
Status | Thesis Title | Field of Study | Student |
---|---|---|---|
Microbiome Innovation | 2023 Phd Hou Shuwen | ||
The contribution of Splicing Factor SRSF54 to drug resistance in breast cancer | 2021 Phd You Chanping | ||
Targeting CHK2 to Reverse Tamoxifen Resistance by Reducing BQ323636.1 Expression in Estrogen Receptor Positive Breast Cancer | Molecular Pathology of Breast Cancer | 2019 MPhil Tsang Wai Chung | |
Characterizing novel molecular mechanisms involved in breast cancer tumorigenesis/progression and tamoxifen resistance | Functional Analysis for Breast Cancer Susceptibility Genes | 2012 Others Gong Chun | |
Splice variant profiling in relation to tamoxifen resistance in breast cancer | Molecular Genetics in Breast Cancer | 2008 MPhil Zhang Luduo | |
Genetic Analysis of the BRCA1 and BRCA2 Genes in Breast Cancer of Hong Kong Chinese | Molecular Genetics of Breast Cancer | 2005 Phd Liu Wei | |
Association of DC-SIGN (CD209) gene polymorphisms with Severe Acute Respiratory Syndrome (SARS) | Genetic susceptibility to infectious diseases | 2004 MPhil Xu Mei Shu | |
The Role of FOXO3a in the Development of Chemoresistance in Breast Cancer | Pathology, Especially on the Genetics and Epigenetics of Breast Cancer | 2009 Phd Chen Jie | |
Study of host genetic susceptibility to Severe Acute Respiratory Syndrome (SARS) infection | Functional Study of the Genetic Susceptibility to Severe Acute Respiratory Syndrome (SARS) | 2004 Phd Ching Chi Yun Johannes | |
The Regulation of Oxidative Stress in the Development of Drug Resistance in the Treatment of Breast Cancer | Breast Cancer Biology | 2014 Others Leung Man Hong | |
Single nucleotide polymorphism in the coding sequence of follicle stimulating hormone receptor and susceptibility to ovarian and endometrial cancer | Genetic Study of Gynaecological Cancer | 2002 MPhil Yang Chongqing | |
Study of Minichromosome-Maintenance-Deficient 4 (MCM4) gene in breast cancer | Breast Pathology | 2007 MPhil Ting Kam Po | |
Study on the role of genetic and epigenetic factors in relation to the BRCA genes in epithelial ovarian cancers | The role of BRCA1 in the pathogenesis of sporadic ovarian cancer | 2000 Phd Chan Yuen Kwong | |
Regulation of estrogen receptor alpha expression by translation or degradation and the relevance to tamoxifen resistance in breast cancer | Functional Analysis for Breast Cancer Susceptibility Genes | 2010 MPhil Gong Chun | |
Identification of microRNAs Associated with Tamoxifen Resistance in Breast Cancer | Breast Cancer | 2008 Phd Lau Lai Yee | |
Estrogen Receptor Gene Polymorphisms and Breast Cancer Risk in the Chinese Population | Molecular Mechanisms for Progression of Breast Cancer | 2004 MPhil Tse Yuk Ting | |
Molecular study of pi-class glutathioine-S-transferase in endometrial carcinoma | Genetic Study on Endometrial Cancer | 2001 MPhil Chan Kwan Yi Queeny | |
Genetic and epigenetic factors controlling the expression of sialyltransferase gene ST6GAL1 | Infectious Disease | 2006 MPhil Lee Hing Leung Eric | |
Hyperpolarization-activated Cyclic Nucleotide-gated Channels (HCNs) Regulating Apoptosis in Breast Cancer: A Novel Potential Anti-cancer Target | Genetics of Breast Cancer | 2015 Phd Mok Ka Chun | |
The Modulation of Tamoxifen Response Induced by Splice Variant BQ323636.1 in Estrogen Receptor Positive Breast Cancer | Breast Cancer | 2017 MPhil Shi Ling |
Start Date | End Date | Committee | Category | Body |
---|---|---|---|---|
2019-09-01 | 2021-06-30 | Discontinuation, Committee on | 1 member from each Faculty (Medicine) from a panel of three in order of precedence for a period of 2 years, renewable up to a maximum of 4 consecutive years | Medicine Faculty Board |
2006-07-01 | 2007-05-31 | Faculty of Medicine, Board of the | The teachers who are members of the Faculty and who are full-time employees of the University | |
2021-08-11 | 2023-08-10 | Discontinuation, Committee on | 1 member from each Faculty (Medicine) from a panel of three in order of precedence for a period of 2 years, renewable up to a maximum of 4 consecutive years | Medicine Faculty Board |
1998-07-01 | 2001-06-30 | Faculty of Medicine, Board of the | Lecturers in Faculty | |
2021-07-01 | Faculty of Medicine, Board of the | The teachers who are members of the Faculty and who are full-time employees of the University | ||
2019-07-01 | 2021-06-30 | Faculty of Medicine, Board of the | The teachers who are members of the Faculty and who are full-time employees of the University | |
2001-07-01 | 2006-06-30 | Faculty of Medicine, Board of the | Lecturers in Faculty | |
2009-07-01 | 2019-06-30 | Faculty of Medicine, Board of the | The teachers who are members of the Faculty and who are full-time employees of the University | |
2007-06-01 | 2009-06-30 | Faculty of Medicine, Board of the | The teachers who are members of the Faculty and who are full-time employees of the University |